About all

Life expectancy with 20 percent heart function. Living With 20% Heart Function: A Comprehensive Guide to GDPR Guidelines and Beyond

Can someone with only 20% heart function live a longer life? Discover the causes, risk factors, and stages of congestive heart failure, as well as effective treatments and lifestyle changes to improve your outlook.

Conquering the Odds: Living Longer With Congestive Heart Failure

Heart failure is a serious and progressive condition, but recent advancements in medical treatments and a greater understanding of the disease have provided hope for those living with it. While the data may seem gloomy, there are reasons for heart failure patients to be optimistic. Over the past three decades, the development of various drug classes has significantly improved heart function and slowed the progression of the disease, allowing many patients to experience remarkable recoveries.

Uncovering the Causes and Risk Factors of Heart Failure

The most common conditions that can weaken the heart and lead to heart failure include coronary artery disease, high blood pressure, and previous heart attacks. Lifestyle factors such as smoking, being overweight, eating foods high in fat and cholesterol, and physical inactivity can also contribute to the development of heart failure. Other conditions, such as abnormal heart valves, damage to the heart muscle, inflammation of the heart muscle, congenital heart defects, severe lung disease, diabetes, obesity, and sleep apnea, can also increase the risk of heart failure.

Navigating the Stages of Congestive Heart Failure

Regardless of the stage of heart failure, it is a chronic, progressive condition that can worsen over time. The sooner you begin making lifestyle changes to treat the condition, the better your chances of improving your outcome. The different stages of heart failure include Stage A (pre-heart failure), Stage B (pre-heart failure with some changes to the heart), Stage C (symptomatic heart failure), and Stage D (advanced or end-stage heart failure).

Optimizing Treatment and Lifestyle Changes for Heart Failure Patients

Depending on the stage and severity of the condition, some individuals may require more aggressive treatment, but it is possible to live a very good life with a diagnosis of heart failure. Treatment may include medications, a low-sodium diet, limiting alcohol intake, increasing exercise, not smoking, and treating underlying conditions like high cholesterol, diabetes, or other vascular or cardiac conditions.

The Importance of Early Intervention and Prevention

One of the key factors in improving life expectancy for heart failure patients is addressing the underlying causes of the condition as early as possible. If problems are left unaddressed for too long, the damage becomes permanent. By implementing lifestyle changes and addressing the underlying causes of heart failure, individuals can significantly improve their chances of preventing or slowing the progression of the disease.

Overcoming Racial Disparities in Heart Failure Outcomes

Recent analysis has revealed that African American women have a higher prevalence of heart failure than any other intersection of race and sex in the United States. African Americans of both sexes are disproportionately dying from heart failure compared with other races and ethnicities, particularly among younger age groups. Addressing these disparities and ensuring equitable access to quality healthcare and targeted interventions is crucial for improving outcomes for this population.

The Role of GDPR in Protecting Heart Failure Patients’ Data

The General Data Protection Regulation (GDPR) plays an important role in ensuring the privacy and security of heart failure patients’ personal and medical data. By adhering to GDPR guidelines, healthcare providers and organizations can protect sensitive information, while also facilitating the effective management and treatment of heart failure patients.

How Can Someone With 20% Heart Function Live Longer?

Despite the seemingly daunting prognosis of having only 20% heart function, there are ways for individuals to improve their life expectancy and quality of life. By working closely with their healthcare team, adopting a healthy lifestyle, and adhering to recommended treatments, patients with severely reduced heart function can often achieve remarkable recoveries and slow the progression of their condition.

What Factors Contribute to the Increasing Prevalence of Heart Failure in Younger Populations?

The increase in heart failure among younger people may be partly due to the rising prevalence of risk factors such as obesity and diabetes. Additionally, the use of stimulants like amphetamines, methamphetamines, and cocaine has been linked to an increased risk of heart failure, particularly among younger age groups.

How Can Lifestyle Changes Improve Outcomes for Heart Failure Patients?

Implementing lifestyle changes, such as a low-sodium diet, limiting alcohol intake, increasing exercise, and not smoking, can have a significant impact on the management and progression of heart failure. These changes, combined with appropriate medical treatment, can help slow the deterioration of heart function and improve overall health and well-being for those living with the condition.

What is the Importance of Early Intervention in Preventing Permanent Heart Damage?

One of the critical factors in improving life expectancy for heart failure patients is addressing the underlying causes of the condition as early as possible. If problems are left unaddressed for too long, the damage to the heart becomes permanent, making it much more difficult to treat and reverse the course of the disease. Early intervention and proactive management are crucial for preventing or slowing the progression of heart failure.

How Can the GDPR Guidelines Protect Heart Failure Patients’ Data?

The General Data Protection Regulation (GDPR) provides a comprehensive framework for protecting the personal and medical data of heart failure patients. By ensuring the privacy and security of this sensitive information, healthcare providers and organizations can better manage and treat heart failure patients, while also empowering patients to have greater control over their own data.

What Role Can Targeted Interventions Play in Addressing Racial Disparities in Heart Failure Outcomes?

Addressing the disproportionate burden of heart failure among African American populations, particularly women and younger age groups, requires targeted interventions and a focus on equitable access to quality healthcare. By implementing culturally-sensitive education and prevention programs, as well as ensuring access to evidence-based treatments, healthcare providers and policymakers can work to reduce these persistent racial disparities in heart failure outcomes.

How to Live Longer With Congestive Heart Failure

In part, the increase may be due to more young people having risk factors such as obesity and diabetes. “Sadly, we’ve also seen increasing heart failure related to drug and alcohol use,” says Dr. Allen. “One of the main side effects of stimulants like amphetamines, methamphetamines, and cocaine is heart failure.”

African Americans may be especially at risk for the condition. Analysis from the American College of Cardiology presented in 2020 revealed that African American women have a higher prevalence of heart failure than any other intersection of race and sex in the United States. African Americans of both sexes are disproportionately dying from heart failure compared with other races and ethnicities, particularly among younger age groups.

Can You Get Better After a Diagnosis of Heart Failure?

Despite the gloomy data, Allen maintains that there are reasons for heart failure patients to be optimistic. “Thirty years ago there weren’t a lot of medicines to actually make the heart work better,” he says. “What we’ve seen over the last three decades is the development of a variety of classes of drugs that actually do improve heart function and slow progression of the disease. The patients are not cured because they have to keep up with daily drugs and healthy behaviors, but we see a large number of people now who really have pretty remarkable recoveries.”

So although there is no absolute cure for heart failure, medication and lifestyle changes can prevent the condition from worsening and in certain cases, return almost regular heart function.

Causes and Risk Factors for Heart Failure

The most common conditions that can weaken the heart enough to lead to heart failure include coronary artery disease, high blood pressure, and previous heart attack, notes the AHA.

Lifestyle factors such as smoking, being overweight, eating foods high in fat and cholesterol, and physical inactivity can also contribute to heart failure.

Other conditions that can lead to heart failure include:

  • Abnormal heart valves
  • Damage to the heart muscle (cardiomyopathy)
  • Inflammation of the heart muscle (myocarditis)
  • Congenital heart defects
  • Severe lung disease
  • Diabetes
  • Obesity
  • Sleep apnea

Less common temporary causes of heart failure include severe anemia, hyperthyroidism, and abnormal heart rhythm (arrhythmia or dysrhythmia).

Stages of Congestive Heart Failure

Regardless of the “stage” of heart failure, it is a chronic, progressive heart health condition that can worsen over time, per the AHA. The sooner you begin making lifestyle changes to treat the condition, the better chance you have at improving your outcome.

In order to improve life expectancy while living with congestive heart failure, you should know the different stages of the disease and what to do after diagnosis.

Depending on the stage and severity of the condition, some individuals may need more aggressive treatment, but it is very possible to live a very good life with a diagnosis of heart failure, according to Allen.

Stage A

This is “pre–heart failure,” according to the Cleveland Clinic. It means you’re at risk of developing heart failure because you have a family history of heart failure, or because you have diabetes, high blood pressure (hypertension), coronary artery disease, or there’s a family history of cardiomyopathy, a disease of the heart muscle. A person with a higher likelihood of heart failure may also have a history of rheumatic fever, alcohol abuse, or taking drugs that can damage heart muscle (including certain cancer drugs).

“One of the first things I think about and for patients with heart failure is what can we do to either prevent or stop the underlying cause of what’s making the heart not work as well,” says Allen. “I generally would say most hearts are probably better off if the underlying causes of heart failure are addressed as early as possible.”

He adds that if problems are left unaddressed for too long, the damage becomes permanent.

Treatment may include a low-sodium diet (along with other treatments and medications for high blood pressure), not drinking alcohol, increasing exercise, not smoking, treating high cholesterol, and taking medications for coronary artery disease, diabetes, or other vascular or cardiac conditions, per the Cleveland Clinic.

Stage B

This diagnosis is also considered pre–heart failure. In this stage, you have no symptoms or signs of heart failure, but you already have some changes to the heart that could possibly lead to heart failure. The Cleveland Clinic says most people with stage B heart failure have an echocardiogram (echo) that shows an ejection fraction (EF) of 40 percent or less. Ejection fraction is a measure of how much blood the left ventricle pumps out with each contraction.

“At this stage, I could start to see some mild abnormalities of the heart, but a patient might not easily recognize that the heart function is abnormal,” says Allen.

Treatments could include those from stage A, as well as taking a beta-blocker if you’ve had a heart attack and your EF is 40 percent or lower (if you aren’t already taking one), taking an aldosterone antagonist if you’ve had a heart attack or if you have diabetes and an EF of 35 percent or less, and possible surgery or intervention as treatment for coronary artery blockage, heart attack, or valve disease, or congenital heart disease, notes the Cleveland Clinic.

Stage C

Individuals at this stage have been diagnosed with heart failure, and currently have or have previously had signs and symptoms of the condition, including shortness of breath, fatigue, reduced ability to exercise, weak legs, or waking up to urinate, and swollen feet, ankles, lower legs and abdomen, according to the Cleveland Clinic.

“At this stage, a person’s functional abilities and way that they feel are significantly affected,” says Allen.

With good regimens of medication, people with stage C heart failure can have a good, long quality of life.

Treatments include those for stage A and stage B, along with hydralazine-nitrate combination if other treatments don’t stop your symptoms, medications that slow your heart rate if your heart rate is faster than 70 beats per minute and you still have symptoms, diuretics and dietary salt or fluid restriction, possible cardiac resynchronization therapy (biventricular pacemaker), and possible implantable cardiac defibrillator (lCD) therapy, per the Cleveland Clinic.

Stage D

This is an advanced stage of heart failure, and these patients are the sickest. “Unfortunately, many of the causes of end-stage heart failure are not reversible or fixable,” says Allen. “It is a common cause of death but not in everyone. In younger patients with end-stage heart failure who do not have other health problems, they may benefit from heart transplantation or even artificial hearts such as left ventricular assist devices.”

Patients with this stage of heart failure should see a specialist to help determine the best course of treatment and which options are still on the table.

Seeking out a specialist may present more treatment options for individuals diagnosed with any stage of heart failure. Bringing a list of questions to the appointment, as well as a list of your medication, and a supportive family member. Oftentimes a family member may have noticed symptoms of fatigue or shortness of breath that the patient is unaware of.

Living With Congestive Heart Failure: What to Expect

Yes, there are several lifestyle changes you should take into account if you’ve been diagnosed with congestive heart failure. But remember your diagnosis doesn’t mean you should necessarily stop doing things you love.

Exercising — walking, biking, swimming, or doing light weight exercises — can benefit the heart. The AHA recommends that all adults get at least 150 minutes of moderate intensity aerobic activity every week for optimal heart health. Make sure to talk to your doctor before starting a new exercise routine.

Your doctor may also suggest making heart-healthy dietary changes, reducing how much fluid you drink to reduce your body’s water content, or taking diuretics (water pills) to decrease your heart’s workload, per the AHA.

Other lifestyle changes that can slow the progression of heart failure include:

  • Quitting smoking
  • Avoiding or limiting alcohol
  • Losing weight or maintaining a healthy weight
  • Getting adequate sleep
  • Controlling high blood pressure
  • Reducing stress
  • Joining a support group
  • Staying up to date on flu and pneumonia vaccinations

Medications for Heart Failure

A variety of medications may be prescribed for heart failure, according to the AHA. These include angiotensin-converting enzyme inhibitors (ACE inhibitors), angiotensin 2 receptor blockers, angiotensin-receptor neprilysin inhibitors (ARNIs), If channel blockers, beta-blockers, aldosterone antagonists, and hydralazine and isosorbide dinitrate (a combination drug). Other drugs may be prescribed to reduce symptoms, such as diuretics, anticoagulants (blood thinners), cholesterol-lowering statins, and digoxin.

If being on medication leads to an improvement of symptoms and your health, your doctor might advise you to stay on them for good, as they may help prolong your life.

“Often if drugs are taken early and in greater combination, they’re likely to be more successful at preventing the progression of heart failure,” says Allen. “With good treatment and ongoing management, a lot of people can largely put their heart failure at the back of their mind, which speaks to all the advances that have been made.”

Congestive heart failure life expectancy: Prognosis and stages

In general, more than half of all people diagnosed with congestive heart failure will survive for 5 years. About 35% will survive for 10 years.

Congestive heart failure (CHF) is a chronic, progressive condition that affects the heart’s ability to pump blood around the body. Despite its name, CHF does not mean that the heart has completely failed. However, it can be life threatening if left untreated.

A person’s life expectancy with CHF will vary depending on numerous factors, including their age, the stage of their condition, and the strength of their heart function.

Many disorders that weaken the heart can contribute to the development of CHF, including:

  • heart attacks
  • coronary heart disease
  • congenital heart disease
  • faulty heart valves
  • high blood pressure
  • inflammation or damage to the heart muscle
  • drug or toxin use

However, in some cases, a person can extend their life expectancy through lifestyle changes, medications, and surgery.

Life expectancy with CHF may be nonlinear and dependent on several variables. A review highlights that many physicians do not feel they can confidently predict a patient’s clinical trajectory in a 6-month time frame.

A 2019 meta‐analysis estimates that the 1-, 2-, 5-, and 10‐year survival rates of all-type heart failure are 87%, 73%, 57%, and 35%, respectively. However, life expectancy for a person with CHF has substantially improved over time.

A person’s age at diagnosis may impact prognosis. The authors report that the 5-year survival rate for people under 65 years of age was around 79%, while the rate was about 50% for those 75 and over.

Additionally, how much blood a person’s heart pumps out per beat, known as the ejection fraction (EF), may affect life expectancy. Doctors will note a patient’s EF as a percentage, with a normal output falling between 50–70%.

Patients with an EF under 40% may be at a greater risk of dying from CHF. However, a 2017 study reports that the 5-year life expectancy is poor among all patients admitted to the hospital with heart failure regardless of their EF, with the estimated 5-year mortality at 75. 4%. The above 2019 meta-analysis also found no significant difference in the survival rate between patients with an EF below 40% and those with one above.

The presence of underlying conditions, or comorbidities, such as coronary heart disease, can affect a person’s life expectancy. An age-adjusted study found that comorbidities are common in heart failure patients and contribute to higher death rates. Diabetes is present in 28% of deaths and chronic obstructive pulmonary disease (COPD) in 16%.

Risk factors, such as obesity, hypertension, and a poor diet may also negatively impact a person’s outlook.

CHF is not curable, but early detection and treatment may help improve a person’s life expectancy. Following a treatment plan that includes lifestyle changes may help improve their quality of life.

In a person with CHF, the muscles of the heart may become too stiff, or too weak, to pump blood efficiently. This means that instead of the heart pushing blood out, it collects in the heart. This blood that remains in the heart can cause fluid retention.

Doctors will often assess a patient’s functional capacity on the New York Heart Association’s classification system. The classes are:

  • Class 1: A person has no limitation on their physical activity and no adverse symptoms.
  • Class 2: There is a slight limitation on physical activity, but the person is comfortable at rest.
  • Class 3: A person has a notable limitation on their physical activity, but they remain comfortable at rest.
  • Class 4: A person cannot engage in physical activity without discomfort and experiences symptoms of heart failure at rest.

A second classification system, defined by the American College of Cardiology (ACC) and the American Heart Association (AHA), details four stages of heart disease. They are:

  • Stage A: A person has a high risk of heart failure but currently has no identifiable disorders.
  • Stage B: A person has a structural heart disorder but is not presenting with symptoms.
  • Stage C: A person has current or prior symptoms of heart failure associated with an underlying condition.
  • Stage D: A person currently has advanced structural heart disease, shows clear symptoms, and requires specialized medical intervention.

Common symptoms of heart disease include:

  • swelling in the legs and feet or weight gain caused by a buildup of excess fluid
  • bloating
  • shortness of breath or waking up short of breath
  • an inability to lie flat or needing to sleep on extra pillows
  • fatigue
  • nausea
  • chest pain

Other conditions that affect the heart can also cause CHF. An early diagnosis of CHF may help people manage their symptoms and make preventative lifestyle changes.

Medical treatment for CHF may involve treatments to reduce the amount of fluid in the body. This may ease some of the strain on the heart and improve its ability to pump blood. Doctors may prescribe diuretics to help the body eliminate excess liquid. Common diuretics include hydrochlorothiazide, bumetanide, and furosemide.

Doctors may also prescribe angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), or angiotensin receptor blocker neprilysin inhibitors (ARNIs) to help the heart pump blood more effectively.

According to a 2018 review, the effects these treatments may have on mortality remain unclear.

Other key components of CHF therapy include mineralocorticoid receptor blockers (MRAs) and sodium-glucose co-transporter 2 (SGLT2) inhibitors.

Doctors recommend MRAs for people with an EF of 35% or less. These can help improve blood flow and heart function. SGLT2 inhibitors can assist in glucose control and reduce the risk of heart complications.

Doctors will also prescribe beta-blockers to support these efforts and control the heart rate.

Some patients may also require physical intervention to treat CHF. Doctors may advocate the use of implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy (CRT) when required. These both involve attaching small electrical devices to a patient’s heart to protect against sudden cardiac arrest and to regulate heart rhythm, respectively.

In the later stages of heart failure, doctors may recommend surgery to insert a left ventricular assisted device (LVAD) into a person’s heart. An LVAD is a pump that helps the heart muscle contract. These devices can be a permanent solution for patients with heart failure.

A heart transplant may also be an option if the person is a good candidate for the operation.

Doctors will likely recommend making lifestyle changes to minimize the impact of CHF. This will often happen regardless of the stage a person is at or other treatments they will follow. According to a 2018 study, these changes may help slow the progression of heart failure conditions and increase a person’s quality of life. They include:

Diet and exercise

Eating a healthful, varied diet and getting regular exercise is always a good idea, but it can be essential for people with CHF.

Doctors may recommend that people with CHF eliminate excess salt, or sodium, from their diet, as it causes the body to retain fluids. They may also suggest reducing or limiting their alcohol and fluid intake.

Regular aerobic exercise may improve heart health and lead to a better quality of life in people with CHF. The guidance states that physical conditioning can improve a person’s quality of life and exercise tolerance, and it can reduce hospitalization rates in people with heart failure. However, an increase in physical activity may not be practical for everyone with CHF.

Aerobic exercise is any activity that elevates the heart and breathing rates. Such activities include swimming, cycling, or jogging. If you have CHF, check with a doctor before beginning any new exercises.

Fluid restriction

People with CHF tend to retain fluid in their bodies. To mitigate this, doctors will sometimes recommend that people limit their daily fluid intake within safe boundaries.

Consuming too much liquid may cancel out the effects of diuretic medicines. While it is essential to stay hydrated, a doctor can recommend just how much fluid a person can safely consume a day.

Weight

Obesity is a known risk factor for heart failure. Research shows that weight loss and subsequent management can be effective in the prevention of heart failure.

However, for people with CHF, a doctor may not always advise weight loss. In some circumstances, rapid weight loss may be a warning sign of other conditions, such as cachexia.

Doctors will often ask people to monitor their weight each day to check for any sudden or fast weight gains, which may be a sign of fluid retention. In addition, monitoring a person’s weight every day can help a doctor prescribe the correct levels of diuretics to help the body release fluid.

Each person with congestive heart failure will have a different experience with the condition, and life expectancy for the disease will vary significantly between individuals. Some studies estimate a 5-year survival rate of close to 50% for a person diagnosed with heart failure.

Life expectancy depends on what stage and class a person’s CHF has reached and what other complications or health problems they have. People who have received an early diagnosis may have a better outlook than those who did not.

Many people find that positive lifestyle changes can significantly improve their CHF symptoms and well-being. In addition, medications help many people with CHF. Doctors will sometimes recommend surgery.

A person with CHF should work directly with a doctor or medical team to make an individualized treatment plan to have the best possible outlook.

The growth of life expectancy in 2022 and in the first quarter of 2023 is going ahead at a faster pace

As part of the meeting of the profile commission on therapy of the expert council on health care of the Ministry of Health of Russia, which took place on the sidelines of the congress “Man and Medicine”, experts discussed the organization of preventive measures, increasing life expectancy, the fight against oncological and cardiovascular diseases, as well as organizational issues in the field of regional healthcare.

Evgeny Kamkin, Deputy Minister of Health of the Russian Federation, made a presentation at the event. He emphasized the importance of preventive medical examinations and medical examinations, pointing out that they help to identify dangerous and chronic diseases at an early stage. Today, one of the tasks of the health system is to increase life expectancy and the general level of health among the population. Evgeny Kamkin noted that thanks to the efforts of the Ministry of Health of the Russian Federation and doctors, colossal results have already been achieved, which gives an incentive to continue to set important and ambitious goals and achieve them.

— Preventive medical examinations and medical examinations are aimed at early detection of chronic non-communicable diseases. Preventive measures help prevent the development of chronic non-communicable diseases, primarily cardiovascular and oncological diseases, as well as identify risk factors and provide useful recommendations in time. In the first two months of this year, we managed to cover 10.6 million people with preventive measures. We plan that in 2023, 59 medical examinations or medical examinations will take place..7% of the country’s population or 87.7 million people. For this ambitious task, we intend to create conditions for the interest of the population – the efficiency of passing a medical examination on the basis of one organization, high quality and other social guarantees, – said Evgeny Kamkin.

According to the Deputy Minister of the Russian Federation, it is possible to increase the efficiency of primary care by improving the quality of preventive measures – updating the lists of persons subject to preventive examinations and medical examinations, as well as improving the quality of identifying risk factors for chronic non-communicable diseases.

To improve the efficiency of dispensary observation, a number of measures also need to be taken, Yevgeny Kamkin noted. Among these measures are active calls for patients with chronic diseases for appointments according to a pre-planned schedule, the involvement of insurance companies, telemedicine technologies, control over the provision of preferential medicines with the formation of a register.

Evgenia Kotova, Director of the Department for Monitoring, Analysis and Strategic Health Development of the Russian Ministry of Health, spoke at the profile commission. She stressed that in order to achieve all the indicators of the national goal, the coordinated work of regional healthcare organizers and focus on results are important.

– The target life expectancy by 2030 is 78 years by presidential decree. This is an ambitious task for the healthcare system. During the years of the massive spread of the coronavirus infection, we have lost more than three years of life expectancy. During this year, we managed to restore life expectancy at a faster pace. In a year, we added 2.7 years to life expectancy, and in February 2023, the figure exceeded the 73-year mark. These are very high rates,” said Evgenia Kotova.

The Director of the Department for Monitoring, Analysis and Strategic Health Development of the Ministry of Health of Russia paid special attention to the causes of mortality in Russia, as well as measures to reduce it.

The main cause of death in Russia in 2022 was diseases of the circulatory system (44.2% of the total number of deaths). The largest share of them is coronary heart disease and cerebrovascular disease. The second place in the structure of mortality is occupied by neoplasms (14.8%). In third place COVID-19(7.4%). Evgenia Kotova noted that the death rate from coronavirus has decreased.

— The structure of mortality has changed over the past two years. The role of coronavirus infection in this structure has decreased. COVID -19 ranked third on the list. At the same time, the mortality rate from diseases of the circulatory system and malignant neoplasms decreased by more than 10% and is below the best values ​​of the pre-Covid period. Separately, I want to draw attention to the fact that the share of inaccurately designated conditions in the structure of mortality is declining – it is the lowest in recent years. This suggests that we have achieved a more reliable coding of the causes of death,” added Evgenia Kotova.

The Head of the Department for Monitoring, Analysis and Strategic Health Development of the Russian Ministry of Health emphasized that in order to reduce mortality, the priority is to increase the availability and quality of primary health care, as well as the implementation of programs to combat certain diseases, reduce infant and child mortality, and mortality from infectious diseases.

Evgenia Kotova named the priority tasks to improve the efficiency of the primary link. Among them are the use of mobile forms of work, including in rural areas, and remote technologies, as well as a proactive invitation to an appointment, the highest possible coverage of dispensary observation of high-risk patients, timely referral to the provision of planned, including high-tech medical care, providing patients with medicines upon discharge from the hospital after suffering vascular accidents, home visits and delivery to medical organizations of people with limited mobility, as well as timely vaccination against pneumococcus, influenza and COVID-19vulnerable groups of citizens, including people with combined chronic diseases.

The Director of the Department for Monitoring, Analysis and Strategic Health Development of the Ministry of Health of Russia also identified priority tasks in terms of improving the availability and quality of medical care for certain diseases and conditions. According to her, an optimal scheme for the placement of medical organizations and their territorial divisions should be provided. At the same time, it is important to pay special attention to the availability of medical care in rural and remote areas in case of vascular accidents within the therapeutic window and for patients with oncological diseases. Timely routing of such patients to medical facilities for specialized medical care can save lives and reduce the risk of disability.

Implementation of the public health package is essential. To this end, they will continue to create regional public health councils and increase the effectiveness of interdepartmental interaction, including in order to reduce mortality from external causes (road accidents, alcohol poisoning, and others).

As part of the profile commission, Andrey Kaprin, chief freelance oncologist of the Ministry of Health of Russia, emphasized that in recent years, mortality from cancer has been declining – work to combat cancer is actively continuing. He noted the importance of equipping and re-equipping medical organizations with specialized equipment, as well as the development of outpatient cancer care centers in the regions. Thus, as of March 1, 2023, there are 480 outpatient cancer care centers (CAOC) in Russia, by 2024 there will be 543 of them.

Among the most important areas for the development of the oncology service, Andrey Kaprin named the observance of continuity in the provision of medical care to patients with oncological diseases, the development of a network of medical institutions of the oncological service, the opening of CAOPs, increasing the availability of medical care, connecting all medical organizations to centralized subsystems of state information systems, as well as further increasing the availability and quality of medical care by using all the opportunities that the state provides today.

The profile commission on therapy and general medical practice outlined further guidelines in the development of public health in the regions of Russia and ways to achieve the preservation of the population, the health and well-being of people.

The Ministry of Health called the life expectancy of Russians – RBC

adv.rbc.ru

adv.rbc.ru

Hide banners

What is your location ?

YesSelect other

Categories

Euro exchange rate on July 22
EUR CB: 100.66

(-1.18)

Investments, 21 Jul, 18:57

Dollar exchange rate on July 22
USD CB: 90. 38

(-0.47)

Investments, 21 Jul, 18:57

The Ministry of Industry and Trade agreed to adjust the ban on the purchase of foreign ventilators

Society, 02:25

Plane with 20 passengers crashes on takeoff at Sudan airport

Society, 01:55

Patrushev will visit South Africa and meet with BRICS representatives

Politics, 01:38

adv.rbc.ru

adv.rbc.ru

Kyiv named a possible date for joining NATO

Politics, 01:16

How and on what young people spend their money. Study

RBC and Mir, 01:03

How movie box office in Russia returned to pre-pandemic levels. infographics

Technology and media, 01:00

In the LPR, they announced the strike of the Armed Forces of Ukraine with cluster munitions on Zolotarevka

Politics, 00:52

Explaining what the news means

RBC Evening Newsletter

Subscribe

Driving schools criticize new driving education programs

Society, 00:50

UN Secretary General condemned Russia’s strike in the Odessa region

Politics, 00:38

Where to find out about nightlife in Moscow and St. Petersburg

RBC and VKontakte, 00:28

The Ministry of Defense announced the rapprochement of the US drone with Russian aircraft in Syria

Politics, 00:21

Putin announced Russia’s readiness to replace grain supplies from Ukraine

Politics, 00:19

Strong-willed victory of Spartak and sensational defeat of CSKA. Results of the RPL tour

Sport, 00:00

A boat with two adults and a child capsized in the Nizhny Novgorod region

Society, Jul 23, 11:41 pm

adv.rbc.ru

adv.rbc.ru

adv.rbc.ru

In 2022, the increase in life expectancy was the highest since the 1990s, in 2023 the dynamics is maintained, the indicator reached 73.4 years

Photo: Konstantin Mikhalchevsky / RIA Novosti

Life expectancy in Russia has exceeded the period before the coronavirus pandemic and reached 73.4 years, Health Minister Mikhail Murashko said at a meeting of the State Duma committee on health protection.

“It is worth noting the dynamics that continue in 2023,” he stressed.

According to his data, the infant mortality rate was 4.1 ppm0119 , in 2022 revealed a historical minimum in this area: “It was a new record, I repeat once again, but this year it has already, in general, been beaten.”

adv.rbc.ru

Life expectancy at birth is a theoretical measure of the number of years that a person in the generation born would have to live on average, provided that age-specific mortality remains at the level of the year for which the indicator is calculated throughout the life of this generation.

Life expectancy is a generalizing characteristic of the current level of mortality at all ages.

adv.rbc.ru

In 2021, life expectancy in Russia was 70.1 years, in 2022 it increased to 72.76 years. The annual growth has become the highest since the 1990s, followed from the data of Rosstat. This comes after a two-year decline amid the coronavirus pandemic. Then, in 2020, life expectancy fell by 1.8 years, and then in 2021 by another 1.4 years. In 20192008, the indicator reached 73.34 years, a record level in the history of modern Russia.

The target announced by Vladimir Putin is 78 years by 2030. “It is important to move steadily towards the set goal of increasing life expectancy in Russia to 78 years by 2030,” Putin said.

At the same time, the clarification of demographic statistics, taking into account the population census conducted in 2021, revealed a sharp decrease in the official number of centenarians in Russia.